20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
AbbVie Inc (ABBV) operates in the Biotechnology industry and is headquartered in North Chicago, United States with about 57,000 employees. Its market capitalization is roughly $466 billion. In the fiscal year ended 2025-12-31, ABBV reported $61.2B in revenue and $4.2B in net income.
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
Interactive charts & full statements → Open the ABBV valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $64.4B | $61.2B | $56.3B | $54.3B | $58.1B | $56.2B | $45.8B | $33.3B | $32.8B | $28.2B | $25.6B | $22.9B | $20.0B | $18.8B | $18.4B | $17.4B | $15.6B | $14.2B |
| Gross Profit | $47.7B | $43.0B | $39.4B | $33.9B | $40.6B | $38.8B | $30.4B | $25.8B | $25.0B | $21.2B | $19.8B | $18.4B | $15.5B | $14.2B | $13.9B | $12.8B | $11.3B | $10.2B |
| Gross Margin % | 74.1% | 70.2% | 70.0% | 62.4% | 70.0% | 69.0% | 66.4% | 77.6% | 76.4% | 75.0% | 77.2% | 80.3% | 77.8% | 75.6% | 75.5% | 73.4% | 72.5% | 71.5% |
| Operating Income (EBIT) | $19.2B | $20.1B | $9.1B | $12.8B | $18.1B | $17.9B | $11.4B | $13.0B | $6.4B | $9.5B | $9.3B | $7.5B | $3.4B | $5.7B | $5.8B | $3.6B | $4.7B | $4.9B |
| Operating Margin % | 29.8% | 32.9% | 16.2% | 23.5% | 31.2% | 31.9% | 24.8% | 39.0% | 19.5% | 33.8% | 36.4% | 33.0% | 17.1% | 30.1% | 31.6% | 20.8% | 30.2% | 34.7% |
| Net Income | $6.3B | $4.2B | $4.3B | $4.9B | $11.8B | $11.5B | $4.6B | $7.9B | $5.7B | $5.3B | $6.0B | $5.1B | $1.8B | $4.1B | $5.3B | $3.4B | $4.2B | $4.6B |
| Net Margin % | 9.8% | 6.9% | 7.6% | 8.9% | 20.4% | 20.5% | 10.1% | 23.7% | 17.4% | 18.8% | 23.2% | 22.5% | 8.9% | 22.0% | 28.7% | 19.7% | 26.7% | 32.6% |
| EBITDA | $19.3B | $17.6B | $14.9B | $17.2B | $24.2B | $23.9B | $12.3B | $12.2B | $8.3B | $10.4B | $10.1B | $8.2B | $3.6B | $6.5B | $7.0B | $4.9B | $6.0B | $5.8B |
| Earnings Per Share (EPS) | $3.57 | $2.38 | $2.41 | $2.74 | $6.66 | $6.50 | $2.76 | $5.31 | $3.68 | $3.31 | $3.65 | $3.14 | $1.10 | $2.57 | $3.34 | $2.11 | $2.57 | $2.85 |
| Shares Outstanding (M) | 1,771M | 1,774M | 1,773M | 1,773M | 1,778M | 1,777M | 1,673M | 1,484M | 1,546M | 1,603M | 1,631M | 1,637M | 1,610M | 1,604M | 1,577M | 1,625M | 1,625M | 1,625M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $17.0B | $15.0B | $16.6B | $15.8B | $15.4B | $13.3B | $15.1B | $14.5B |
| Gross Profit | $14.4B | $10.8B | $12.1B | $10.5B | $11.1B | $9.3B | $10.7B | $10.2B |
| Gross Margin % | 84.7% | 71.9% | 72.6% | 66.4% | 71.8% | 70.0% | 70.9% | 70.9% |
| Operating Income (EBIT) | $6.7B | $4.7B | $5.8B | $1.9B | $4.9B | $3.7B | ($1.5B) | $3.8B |
| Operating Margin % | 39.6% | 31.6% | 35.0% | 12.1% | 31.7% | 28.0% | -9.9% | 26.5% |
| Net Income | $3.6B | $699M | $1.8B | $186M | $938M | $1.3B | ($22M) | $1.6B |
| Net Margin % | 21.3% | 4.7% | 10.9% | 1.2% | 6.1% | 9.6% | -0.1% | 10.8% |
| EBITDA | $6.7B | $3.7B | $5.4B | $3.5B | $4.3B | $4.4B | $535M | $4.9B |
| Earnings Per Share (EPS) | $2.04 | $0.39 | $1.02 | $0.10 | $0.53 | $0.73 | $-0.01 | $0.88 |
| Shares Outstanding (M) | 1,771M | 1,774M | 1,774M | 1,772M | 1,772M | 1,772M | 1,773M | 1,772M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $19.5B | $19.0B | $18.8B | $22.8B | $24.9B | $22.8B | $17.6B | $13.3B | $13.4B | $10.0B | $7.0B | $7.5B | $3.5B | $6.3B | $6.3B | $6.2B | $5.0B | $5.4B |
| Capital Expenditures (CapEx) | $1.4B | $1.2B | $974M | $777M | $695M | $787M | $798M | $552M | $638M | $529M | $479M | $532M | $612M | $491M | $333M | $356M | $448M | $313M |
| Free Cash Flow (FCF) | $18.1B | $17.8B | $17.8B | $22.1B | $24.2B | $22.0B | $16.8B | $12.8B | $12.8B | $9.4B | $6.6B | $7.0B | $2.9B | $5.8B | $6.0B | $5.9B | $4.5B | $5.1B |
| FCF Margin % | 28.2% | 29.1% | 31.6% | 40.6% | 41.8% | 39.1% | 36.7% | 38.4% | 39.1% | 33.4% | 25.6% | 30.6% | 14.7% | 30.7% | 32.7% | 33.8% | 29.0% | 35.6% |
| Dividends Paid | $12.0B | $11.7B | $11.0B | $10.5B | $10.0B | $9.3B | $7.7B | $6.4B | $5.6B | $4.1B | $3.7B | $3.3B | $2.7B | $2.6B | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $3.4B | $3.8B | $5.2B | $7.0B | $5.2B | $1.6B | $7.0B | $5.4B |
| Capital Expenditures (CapEx) | $265M | $265M | $329M | $504M | $269M | $235M | $291M | $249M |
| Free Cash Flow (FCF) | $3.2B | $3.6B | $4.9B | $6.5B | $4.9B | $1.4B | $6.8B | $5.2B |
| FCF Margin % | 18.7% | 23.8% | 29.4% | 41.3% | 31.7% | 10.5% | 44.7% | 35.9% |
| Dividends Paid | $3.1B | $3.1B | $2.9B | $2.9B | $2.9B | $2.9B | $2.8B | $2.8B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $135.1B | $134.0B | $135.2B | $134.7B | $138.8B | $146.5B | $150.6B | $89.1B | $59.4B | $70.8B | $66.1B | $53.0B | $27.5B | $29.2B | $27.0B | $19.5B | $21.1B |
| Cash & Cash Equivalents | $6.6B | $5.2B | $5.5B | $12.8B | $9.2B | $9.7B | $8.4B | $39.9B | $7.3B | $9.3B | $5.1B | $8.4B | $8.3B | $9.6B | $5.9B | $27M | $10M |
| Total Liabilities | $141.0B | $137.2B | $131.8B | $124.3B | $121.5B | $131.1B | $137.5B | $97.3B | $67.8B | $65.7B | $61.5B | $49.1B | $25.8B | $24.7B | $23.6B | $7.6B | $5.4B |
| Total Debt (Short + Long-Term) | $8.3B | $67.7B | $67.1B | $59.4B | $63.4B | $76.9B | $86.2B | $66.7B | $40.3B | $37.4B | $36.8B | $31.7B | $15.0B | $14.7B | $15.7B | $53M | $0M |
| Total Shareholders' Equity | ($5.9B) | ($3.2B) | $3.4B | $10.4B | $17.3B | $15.4B | $13.1B | ($8.2B) | ($8.4B) | $5.1B | $4.6B | $3.9B | $1.7B | $4.5B | $3.4B | $11.9B | $15.7B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ABBV viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms